The following is a list of recent research reports by analysts who have given permission for publication/listing on this website.

Bioshares issue 244
10/12/2007

CCM Research Report, October 2007
26/10/2007

Merriman Curhan Ford & Co - VivaGel Condom-Coating Partnership; Positive Phase I and Fiscal Year Financial Results Announced
4/09/2007

Merriman Curhan Ford & Co - Versatile Core Technology and Validating Contracts for Unmet Medical Need
20/06/2007

Starpharma - Has it found the 'Holy Grail' for siRNA Drug Developers?
12/06/2007

CCM Research Report, May 2007
7/06/2007

Patersons Securities - SPL Delivers First Deal from DNT Acquisition
5/03/2007

Patersons Securities - Biotechnology 2007 – The Year Ahead
6/02/2007

Bioshares issue 188 - The Rationale Behind Starpharma's Acquisition of DNT
13/10/2006

Patersons Securities - Research Note - Starpharma Acquires DNT
9/10/2006

Patersons Securities - Research Note - CEO Appointment and Update
3/07/2006

Bioshares issue 171 - Starpharma VivaGel™ Delivers Added Bonus
16/06/2006

Bioshares issue 163 - Starpharma Wins Further Non-dilutive Funding and Validation
21/04/2006

Please note that any opinions, estimates or forecasts regarding Starpharma's performance made by analysts mentioned on this website are theirs alone and do not represent opinions, forecasts or predictions of Starpharma or its management. Starpharma does not by its reference to any analysts imply its endorsement of or concurrence with their information, conclusions, or recommendations. Information provided by analysts is subject to change, and Starpharma cannot guarantee its accuracy.